A detailed history of Mc Donough Capital Management, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mc Donough Capital Management, Inc holds 9,414 shares of PFE stock, worth $243,728. This represents 0.19% of its overall portfolio holdings.

Number of Shares
9,414
Previous 9,534 1.26%
Holding current value
$243,728
Previous $266,000 2.26%
% of portfolio
0.19%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $3,324 - $3,766
-120 Reduced 1.26%
9,414 $272,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $5,506 - $6,452
218 Added 2.34%
9,534 $266,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $2,796 - $3,210
108 Added 1.17%
9,316 $258,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $3,161 - $4,106
121 Added 1.33%
9,208 $265,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $5,455 - $6,376
-170 Reduced 1.84%
9,087 $301,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $3,250 - $3,761
90 Added 0.98%
9,257 $339,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $12,092 - $15,742
-307 Reduced 3.24%
9,167 $374,000
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $2,755 - $3,597
66 Added 0.7%
9,474 $485,000
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $3,194 - $3,899
73 Added 0.78%
9,408 $412,000
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $1,070 - $1,268
-23 Reduced 0.25%
9,335 $489,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $3,111 - $3,854
68 Added 0.73%
9,358 $484,000
Q4 2021

Feb 18, 2022

BUY
$41.32 - $61.25 $383,862 - $569,012
9,290 New
9,290 $549,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mc Donough Capital Management, Inc Portfolio

Follow Mc Donough Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Donough Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mc Donough Capital Management, Inc with notifications on news.